Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Inflammatory Breast Neoplasms”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Not applicableLooking for participantsNCT04636710
What this trial is testing

Refining Local-Regional Therapy for IBC

Who this might be right for
Breast CancerInflammatory Breast CancerSentinel Lymph Node
Dana-Farber Cancer Institute 50
Large-scale testing (Phase 3)Study completedNCT01806259
What this trial is testing

Ketorolac in Breast Cancer Surgery

Who this might be right for
Curative Breast Cancer SurgeryInflammatory Positive/Negative StatusPre Surgical Incision Administration
Université Catholique de Louvain 203
Testing effectiveness (Phase 2)UnknownNCT00002627
What this trial is testing

Addition of Paclitaxel to High-Dose Combination Chemotherapy in Treating Patients With High-Risk Breast Cancer

Who this might be right for
Breast Cancer
St. Louis University 30
Testing effectiveness (Phase 2)Ended earlyNCT03184558
What this trial is testing

Bemcentinib (BGB324) in Combination With Pembrolizumab in Patients With TNBC

Who this might be right for
Triple Negative Breast CancerInflammatory Breast Cancer Stage IV
BerGenBio ASA 29
Testing effectiveness (Phase 2)Active Not RecruitingNCT02876107
What this trial is testing

Carboplatin and Paclitaxel With or Without Panitumumab in Treating Patients With Invasive Triple Negative Breast Cancer

Who this might be right for
Breast CarcinomaBreast LumpEdema+8 more
M.D. Anderson Cancer Center 42
Testing effectiveness (Phase 2)Ended earlyNCT05198843
What this trial is testing

Testing an Omega-3 Fatty Acid-Based Anti-Cancer Therapy for Patients With Triple-Negative Inflammatory Breast Cancer That Has Spread to Other Parts of the Body

Who this might be right for
Anatomic Stage IV Breast Cancer AJCC v8Metastatic Triple-Negative Breast Inflammatory Carcinoma
National Cancer Institute (NCI) 1
Not applicableUnknownNCT05113485
What this trial is testing

UCLA Breast Cancer Survivor Health Promotion Research Study

Who this might be right for
Breast Cancer
University of California, Los Angeles 30
Testing effectiveness (Phase 2)Active Not RecruitingNCT04215146
What this trial is testing

Assess Overall Response Rate by Inducing an Inflammatory Phenotype in Metastatic BReast cAnCEr With the Oncolytic Reovirus PeLareorEp in CombinaTion With Anti-PD-L1 Avelumab and Paclitaxel - BRACELET-1 Study

Who this might be right for
Breast Cancer Metastatic
Oncolytics Biotech 48
Not applicableLooking for participantsNCT04616300
What this trial is testing

Exercise and Cognitive (Brain) Function in Breast Cancer Patients Getting Chemotherapy After Breast Surgery

Who this might be right for
Breast Cancer
University of Toronto 50
Large-scale testing (Phase 3)Ended earlyNCT00028704
What this trial is testing

Breast-Conserving Therapy Compared With Mastectomy Followed By Radiation Therapy in Treating Women With Locally Advanced Breast Cancer Previously Treated With Chemotherapy

Who this might be right for
Breast Cancer
European Organisation for Research and Treatment of Cancer - EORTC 26
Testing effectiveness (Phase 2)Study completedNCT00943410
What this trial is testing

Trastuzumab and External Beam Radiation Therapy in Treating Women With Stage III or Stage IV Breast Cancer

Who this might be right for
Breast Cancer
UNC Lineberger Comprehensive Cancer Center 19
Early research (Phase 1)WithdrawnNCT05093387
What this trial is testing

SGT-53, Carboplatin, and Pembrolizumab for the Treatment of Metastatic Triple Negative Inflammatory Breast Cancer

Who this might be right for
Anatomic Stage IV Breast Cancer AJCC v8Breast Inflammatory CarcinomaMetastatic Triple-Negative Breast Carcinoma+1 more
Northwestern University
Early research (Phase 1)UnknownNCT06065592
What this trial is testing

Exploring Cancer-Associated Thromboembolism Prognosis Biomarkers and Polymorphisms

Who this might be right for
CancerSolid TumorThromboembolism+10 more
Lebanese University 500
Not applicableActive Not RecruitingNCT05632601
What this trial is testing

Reexamining Her Cardiovascular Risk - Ottawa WomeN's Longitudinal Cohort Study

Who this might be right for
Cardiovascular Diseases
Ottawa Heart Institute Research Corporation 176
Not applicableNot Yet RecruitingNCT07583719
What this trial is testing

Effects of Moderate-intensity Interval Aerobic Exercise (MIIAE) on Inflammatory, Immune, Metabolic, Physical Fitness, and Quality of Life Parameters in Breast Cancer Patients Undergoing Radiotherapy.

Who this might be right for
RadiotherapyInflamationImmune System+2 more
Universidad Francisco de Vitoria 40
Not applicableLooking for participantsNCT05740787
What this trial is testing

Chemotherapy Induced Cognitive Impairment

Who this might be right for
Breast Cancer
University of Aberdeen 50
Testing effectiveness (Phase 2)Study completedNCT00545688
What this trial is testing

Pertuzumab in Combination With Herceptin in Patients With HER2 Positive Breast Cancer.

Who this might be right for
Breast Cancer
Hoffmann-La Roche 417
Testing effectiveness (Phase 2)Study completedNCT00006110
What this trial is testing

Multimodality Treatment for Women With Stage II, Stage III, or Stage IV Breast Cancer

Who this might be right for
Breast Cancer
UNC Lineberger Comprehensive Cancer Center 82
Not applicableLooking for participantsNCT07080944
What this trial is testing

Sentinel Lymph Node Biopsy After Neoadjuvant Chemotherapy in IBC

Who this might be right for
Invasive Breast CarcinomaSentinel Lymph Node Biopsy (SLNB)Neoadjuvant Chemotherapy
European Institute of Oncology 75
Testing effectiveness (Phase 2)Study completedNCT03742986
What this trial is testing

Trial of Nivolumab With Chemotherapy as Neoadjuvant Treatment in Inflammatory Breast Cancer (IBC)

Who this might be right for
Breast Cancer
NYU Langone Health 8
Next Page